vs
Astrana Health, Inc.（ASTH）与泰瑞达（TER）财务数据对比。点击上方公司名可切换其他公司
泰瑞达的季度营收约是Astrana Health, Inc.的1.1倍（$1.1B vs $950.5M），泰瑞达净利率更高（23.7% vs 0.7%，领先23.1%），泰瑞达同比增速更快（43.9% vs 42.9%），泰瑞达自由现金流更多（$218.8M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 34.4%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
泰瑞达是总部位于美国马萨诸塞州北雷丁的自动测试设备（ATE）设计及制造企业，在全球半导体测试领域拥有深厚技术积累，服务的知名客户涵盖三星、高通、英特尔、亚德诺、德州仪器、IBM等行业头部企业。
ASTH vs TER — 直观对比
营收规模更大
TER
是对方的1.1倍
$950.5M
营收增速更快
TER
高出1.0%
42.9%
净利率更高
TER
高出23.1%
0.7%
自由现金流更多
TER
多$224.7M
$-6.0M
两年增速更快
ASTH
近两年复合增速
34.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.1B |
| 净利润 | $6.6M | $257.2M |
| 毛利率 | — | 57.2% |
| 营业利润率 | 1.9% | 27.1% |
| 净利率 | 0.7% | 23.7% |
| 营收同比 | 42.9% | 43.9% |
| 净利润同比 | 184.4% | 75.9% |
| 每股收益（稀释后） | $0.12 | $1.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHTER
| Q4 25 | $950.5M | $1.1B | ||
| Q3 25 | $956.0M | $769.2M | ||
| Q2 25 | $654.8M | $651.8M | ||
| Q1 25 | $620.4M | $685.7M | ||
| Q4 24 | $665.2M | $752.9M | ||
| Q3 24 | $478.7M | $737.3M | ||
| Q2 24 | $486.3M | $729.9M | ||
| Q1 24 | $404.4M | $599.8M |
净利润ASTHTER
| Q4 25 | $6.6M | $257.2M | ||
| Q3 25 | $373.0K | $119.6M | ||
| Q2 25 | $9.4M | $78.4M | ||
| Q1 25 | $6.7M | $98.9M | ||
| Q4 24 | $-7.8M | $146.3M | ||
| Q3 24 | $16.1M | $145.6M | ||
| Q2 24 | $19.2M | $186.3M | ||
| Q1 24 | $14.8M | $64.2M |
毛利率ASTHTER
| Q4 25 | — | 57.2% | ||
| Q3 25 | — | 58.4% | ||
| Q2 25 | — | 57.2% | ||
| Q1 25 | — | 60.6% | ||
| Q4 24 | — | 59.4% | ||
| Q3 24 | — | 59.2% | ||
| Q2 24 | — | 58.3% | ||
| Q1 24 | — | 56.6% |
营业利润率ASTHTER
| Q4 25 | 1.9% | 27.1% | ||
| Q3 25 | 2.0% | 18.9% | ||
| Q2 25 | 3.1% | 13.9% | ||
| Q1 25 | 3.3% | 17.6% | ||
| Q4 24 | 0.1% | 20.4% | ||
| Q3 24 | 5.9% | 20.6% | ||
| Q2 24 | 6.2% | 28.8% | ||
| Q1 24 | 7.5% | 13.0% |
净利率ASTHTER
| Q4 25 | 0.7% | 23.7% | ||
| Q3 25 | 0.0% | 15.5% | ||
| Q2 25 | 1.4% | 12.0% | ||
| Q1 25 | 1.1% | 14.4% | ||
| Q4 24 | -1.2% | 19.4% | ||
| Q3 24 | 3.4% | 19.8% | ||
| Q2 24 | 3.9% | 25.5% | ||
| Q1 24 | 3.7% | 10.7% |
每股收益（稀释后）ASTHTER
| Q4 25 | $0.12 | $1.62 | ||
| Q3 25 | $0.01 | $0.75 | ||
| Q2 25 | $0.19 | $0.49 | ||
| Q1 25 | $0.14 | $0.61 | ||
| Q4 24 | $-0.14 | $0.89 | ||
| Q3 24 | $0.33 | $0.89 | ||
| Q2 24 | $0.40 | $1.14 | ||
| Q1 24 | $0.31 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $293.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $2.8B |
| 总资产 | $2.2B | $4.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHTER
| Q4 25 | $429.5M | $293.8M | ||
| Q3 25 | $463.4M | $272.7M | ||
| Q2 25 | $342.1M | $339.3M | ||
| Q1 25 | $260.9M | $475.6M | ||
| Q4 24 | $290.8M | $553.4M | ||
| Q3 24 | $350.3M | $510.0M | ||
| Q2 24 | $327.7M | $421.9M | ||
| Q1 24 | $337.3M | $707.4M |
股东权益ASTHTER
| Q4 25 | $779.3M | $2.8B | ||
| Q3 25 | $775.5M | $2.7B | ||
| Q2 25 | $765.5M | $2.8B | ||
| Q1 25 | $745.4M | $2.8B | ||
| Q4 24 | $712.7M | $2.8B | ||
| Q3 24 | $704.6M | $2.9B | ||
| Q2 24 | $678.9M | $2.7B | ||
| Q1 24 | $653.5M | $2.6B |
总资产ASTHTER
| Q4 25 | $2.2B | $4.2B | ||
| Q3 25 | $2.2B | $4.0B | ||
| Q2 25 | $1.4B | $3.8B | ||
| Q1 25 | $1.3B | $3.7B | ||
| Q4 24 | $1.4B | $3.7B | ||
| Q3 24 | $1.3B | $3.8B | ||
| Q2 24 | $1.3B | $3.6B | ||
| Q1 24 | $1.2B | $3.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $281.6M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $218.8M |
| 自由现金流率自由现金流/营收 | -0.6% | 20.2% |
| 资本支出强度资本支出/营收 | 0.3% | 5.8% |
| 现金转化率经营现金流/净利润 | -0.44× | 1.09× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $450.4M |
8季度趋势，按日历期对齐
经营现金流ASTHTER
| Q4 25 | $-2.9M | $281.6M | ||
| Q3 25 | $10.0M | $49.0M | ||
| Q2 25 | $90.9M | $182.1M | ||
| Q1 25 | $16.6M | $161.6M | ||
| Q4 24 | $-10.9M | $282.6M | ||
| Q3 24 | $34.0M | $166.3M | ||
| Q2 24 | $23.2M | $216.1M | ||
| Q1 24 | $6.0M | $7.3M |
自由现金流ASTHTER
| Q4 25 | $-6.0M | $218.8M | ||
| Q3 25 | $7.4M | $2.4M | ||
| Q2 25 | $89.5M | $131.7M | ||
| Q1 25 | $13.6M | $97.6M | ||
| Q4 24 | $-13.5M | $225.2M | ||
| Q3 24 | $31.7M | $114.4M | ||
| Q2 24 | $20.4M | $171.2M | ||
| Q1 24 | $5.6M | $-36.7M |
自由现金流率ASTHTER
| Q4 25 | -0.6% | 20.2% | ||
| Q3 25 | 0.8% | 0.3% | ||
| Q2 25 | 13.7% | 20.2% | ||
| Q1 25 | 2.2% | 14.2% | ||
| Q4 24 | -2.0% | 29.9% | ||
| Q3 24 | 6.6% | 15.5% | ||
| Q2 24 | 4.2% | 23.5% | ||
| Q1 24 | 1.4% | -6.1% |
资本支出强度ASTHTER
| Q4 25 | 0.3% | 5.8% | ||
| Q3 25 | 0.3% | 6.1% | ||
| Q2 25 | 0.2% | 7.7% | ||
| Q1 25 | 0.5% | 9.3% | ||
| Q4 24 | 0.4% | 7.6% | ||
| Q3 24 | 0.5% | 7.0% | ||
| Q2 24 | 0.6% | 6.1% | ||
| Q1 24 | 0.1% | 7.3% |
现金转化率ASTHTER
| Q4 25 | -0.44× | 1.09× | ||
| Q3 25 | 26.69× | 0.41× | ||
| Q2 25 | 9.65× | 2.32× | ||
| Q1 25 | 2.48× | 1.63× | ||
| Q4 24 | — | 1.93× | ||
| Q3 24 | 2.11× | 1.14× | ||
| Q2 24 | 1.21× | 1.16× | ||
| Q1 24 | 0.40× | 0.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
TER
| Soc | $646.5M | 60% |
| Memory | $206.5M | 19% |
| Transferred At Point In Time | $90.0M | 8% |
| Universal Robots | $89.4M | 8% |
| IST | $30.5M | 3% |
| Transferred Over Time | $20.5M | 2% |
